CCL2 and neoplasm: The overexpression of CCL2 and resultant promotion of tumor growth have also been observed in breast [11, 12], ovarian [13], esophageal [14], gastric [15], renal cell [16], lung [17], colon [18], and papillary thyroid cancers [19].